CAN
TCRT icon

Cetera Advisor Networks’s Alaunos Therapeutics TCRT Stock Holding History

Cetera Advisor Networks’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-88
Closed -$930 – 2924
2023
Q4 		$930 Hold
88
– – ﹤0.01% 2773
2023
Q3 		$1.73K Buy
88
+6
+7% +$258 ﹤0.01% 2702
2023
Q2 		$6.3K Hold
82
– – ﹤0.01% 2584
2023
Q1 		$7.79K Sell
82
-7
-8% -$666 ﹤0.01% 2562
2022
Q4 		$8.71K Hold
89
– – ﹤0.01% 2512
2022
Q3 		$23K Hold
89
– – ﹤0.01% 2044
2022
Q2 		$17K Buy
+89
New +$8.51K ﹤0.01% 2036
2020
Q3 		– Sell
-52
Closed -$26K – 2834
2020
Q2 		$26K Buy
+52
New +$23.2K ﹤0.01% 2261

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Cetera Advisor Networks's TCRT Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 88 shares — an estimated $930 sold.

Cetera Advisor Networks first reported a position in TCRT in Q2 2020 and held it in 8 quarters. The position peaked at $26K in Q2 2020. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 88 Alaunos Therapeutics shares in Q1 2024, an estimated $930.
  • Cetera Advisor Networks first reported a position in Alaunos Therapeutics in Q2 2020 and held it in 8 quarters.
  • Cetera Advisor Networks's Alaunos Therapeutics position peaked at $26K in Q2 2020.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.